{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:41:28Z","timestamp":1790674888610,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd011451","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T00:00:00Z","timestamp":1546646400000}}],"reference-count":154,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011451.pub2","type":"journal-article","created":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T07:23:26Z","timestamp":1546673006000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Acetyl-L-carnitine for patients with hepatic encephalopathy"],"prefix":"10.1002","volume":"2019","author":[{"given":"Arturo J","family":"Mart\u00ed-Carvajal","sequence":"first","affiliation":[{"name":"Iberoamerican Cochrane Network; Valencia Venezuela"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Arevalo-Rodriguez","sequence":"additional","affiliation":[{"name":"Hospital Universitario Ramon y Cajal (IRYCIS); Clinical Biostatistics Unit; Madrid Spain"},{"name":"CIBER Epidemiology and Public Health (CIBERESP); Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Elena","family":"Mart\u00ed-Amarista","sequence":"additional","affiliation":[{"name":"Northwell Health Southside Hospital; Department of Family Medicine; 301 East Main Street Bay Shore New York USA 11706"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,1,5]]},"reference":[{"issue":"12","key":"10.1002\/14651858.CD011451.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1007\/s10620-006-9187-0","article-title":"Effects of L-acetylcarnitine on cirrhotic patients with hepatic coma: randomized double-blind, placebo-controlled trial","volume":"51","author":"Malaguarnera","year":"2006","journal-title":"Digestive Diseases and Sciences"},{"issue":"11","key":"10.1002\/14651858.CD011451.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1007\/s10620-008-0238-6","article-title":"Acetyl-L-carnitine treatment in minimal hepatic encephalopathy","volume":"53","author":"Malaguarnera","year":"2008","journal-title":"Digestive Diseases and Sciences"},{"issue":"6","key":"10.1002\/14651858.CD011451.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3109\/00365521.2011.565067","article-title":"Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy","volume":"46","author":"Malaguarnera","year":"2011","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD011451.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3945\/ajcn.110.007393","article-title":"Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study","volume":"93","author":"Malaguarnera","year":"2011","journal-title":"American Journal of Clinical Nutrition"},{"issue":"4","key":"10.1002\/14651858.CD011451.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11011-011-9260-z","article-title":"Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial","volume":"26","author":"Malaguarnera","year":"2011","journal-title":"Metabolic Brain Disease"},{"issue":"5","key":"10.1002\/14651858.CD011451.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1665-2681(19)31323-7","article-title":"Oral acetyl-L-carnitine treatment in hepatic encephalopathy: view of evidence-based medicine","volume":"12","author":"Jiang","year":"2013","journal-title":"Annals of Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD011451.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"e11608","DOI":"10.5812\/hepatmon.11608","article-title":"Acetyl-L-carnitine supplementation during HCV therapy with pegylated interferon-\u03b1 2b plus ribavirin: effect on work performance; a randomized clinical trial","volume":"14","author":"Malaguarnera","year":"2014","journal-title":"Hepatitis Monthly"},{"issue":"1-2","key":"10.1002\/14651858.CD011451.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1440-1681.2006.04327.x","article-title":"Effects of a single, short intravenous dose of acetyl-L-carnitine on pattern-reversal visual-evoked potentials in cirrhotic patients with hepatic encephalopathy","volume":"33","author":"Siciliano","year":"2006","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0009|cit9","unstructured":"Acetyl-L-carnitine reduces perceived work stress and improves work ability and work performance in hepatic encephalopathy Ongoing study April 2010"},{"issue":"2","key":"10.1002\/14651858.CD011451.pub2-BIB0010|cit10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002798.pub2","article-title":"Benzodiazepine receptor antagonists for hepatic encephalopathy","author":"Als-Nielsen","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7003","key":"10.1002\/14651858.CD011451.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/bmj.311.7003.485","article-title":"Absence of evidence is not evidence of absence","volume":"311","author":"Altman","year":"1995","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"6","key":"10.1002\/14651858.CD011451.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/SLA.0000000000001795","article-title":"Reporting of randomized controlled trials with statistically nonsignificant primary outcomes published in high-impact surgical journals","volume":"265","author":"Arunachalam","year":"2016","journal-title":"Annals of Surgery"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0013|cit13","doi-asserted-by":"crossref","unstructured":"Backmann M What's in a gold standard? In defence of randomised controlled trials Medicine, Health Care, and Philosophy 2017 513 23","DOI":"10.1007\/s11019-017-9773-2"},{"issue":"4","key":"10.1002\/14651858.CD011451.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.cgh.2016.09.157","article-title":"Hepatic encephalopathy Is associated with mortality in patients with cirrhosis independent of other extrahepatic organ failures","volume":"15","author":"Bajaj","year":"2017","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD011451.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD011451.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cld.2015.05.003","article-title":"Clinical and neurologic manifestation of minimal hepatic encephalopathy and overt hepatic encephalopathy","volume":"19","author":"Basu","year":"2015","journal-title":"Clinics in Liver Disease"},{"issue":"3","key":"10.1002\/14651858.CD011451.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/0962280207080639","article-title":"On improving research methodology in clinical trials","volume":"17","author":"Berger","year":"2008","journal-title":"Statistical Methods in Medical Research"},{"issue":"1","key":"10.1002\/14651858.CD011451.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jrsm.1230","article-title":"Basics of meta-analysis: I2 is not an absolute measure of heterogeneity","volume":"8","author":"Borenstein","year":"2017","journal-title":"Research Synthesis Methods"},{"issue":"20","key":"10.1002\/14651858.CD011451.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1001\/jama.2010.651","article-title":"Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes","volume":"303","author":"Boutron","year":"2010","journal-title":"JAMA"},{"issue":"8","key":"10.1002\/14651858.CD011451.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","article-title":"Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses","volume":"61","author":"Brok","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD011451.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ije\/dyn188","article-title":"Apparently conclusive meta-analyses may be inconclusive - trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses","volume":"38","author":"Brok","year":"2009","journal-title":"International Journal of Epidemiology"},{"issue":"33","key":"10.1002\/14651858.CD011451.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta5330","article-title":"Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives","volume":"5","author":"Brookes","year":"2001","journal-title":"Health Technology Assessment"},{"issue":"1","key":"10.1002\/14651858.CD011451.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13643-018-0770-1","article-title":"Assessing imprecision in Cochrane systematic reviews: a comparison of GRADE and Trial Sequential Analysis","volume":"7","author":"Castellini","year":"2018","journal-title":"Systematic Reviews"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0024|cit24","doi-asserted-by":"crossref","unstructured":"Chaimani A Mavridis D Salanti G A hands-on practical tutorial on performing meta-analysis with Stata Evidence-Based Mental Health 2014 111 6","DOI":"10.1136\/eb-2014-101967"},{"issue":"2","key":"10.1002\/14651858.CD011451.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0022-3999(93)90081-P","article-title":"Development of a fatigue scale","volume":"37","author":"Chalder","year":"1993","journal-title":"Journal of Psychosomatic Research"},{"issue":"3","key":"10.1002\/14651858.CD011451.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 statement: defining standard protocol items for clinical trials","volume":"158","author":"Chan","year":"2013","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0027|cit27","doi-asserted-by":"crossref","unstructured":"Ciapponi A Glujovsky D Bardach A Garc\u00eda Mart\u00ed S Comande D EROS: a new software for early stage of systematic reviews ISPOR 3rd Latin America Conference Mexico City Hilton Mexico City Reforma 2011","DOI":"10.1016\/j.jval.2011.08.1689"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1745-6215-8-39","article-title":"Standardising outcomes for clinical trials and systematic reviews","volume":"8","author":"Clarke","year":"2007","journal-title":"Trials"},{"issue":"6","key":"10.1002\/14651858.CD011451.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/BF01072510","article-title":"Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy","volume":"22","author":"Conn","year":"1977","journal-title":"American Journal of Digestive Diseases"},{"issue":"2","key":"10.1002\/14651858.CD011451.pub2-BIB0030|cit30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008716.pub3","article-title":"Probiotics for people with hepatic encephalopathy","author":"Dalal","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD011451.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1586\/17474124.2016.1141675","article-title":"Recent developments in the diagnosis and treatment of covert\/minimal hepatic encephalopathy","volume":"10","author":"Rui","year":"2016","journal-title":"Expert Review of Gastroenterology and Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD011451.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.7326\/0003-4819-155-1-201107050-00006","article-title":"Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study","volume":"155","author":"Dechartres","year":"2011","journal-title":"Annals of Internal Medicine"},{"issue":"16","key":"10.1002\/14651858.CD011451.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1002\/sim.6909","article-title":"Type-II generalized family-wise error rate formulas with application to sample size determination","volume":"35","author":"Delorme","year":"2016","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3389\/fpsyg.2014.00781","article-title":"Using Bayes to get the most out of non-significant results","volume":"5","author":"Dienes","year":"2014","journal-title":"Frontiers in Psychology"},{"issue":"7","key":"10.1002\/14651858.CD011451.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"e66844","DOI":"10.1371\/journal.pone.0066844","article-title":"Systematic review of the empirical evidence of study publication bias and outcome reporting bias - an updated review","volume":"8","author":"Dwan","year":"2013","journal-title":"PloS One"},{"issue":"1","key":"10.1002\/14651858.CD011451.pub2-BIB0036|cit36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006314","article-title":"Antibiotics for hepatic encephalopathy","author":"Falavigna","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0037|cit37","unstructured":"Food Drug Administration FDA briefing document. Pharmacy Compounding Advisory Committee (PCAC) meeting www.fda.gov\/AdvisoryCommittees\/CommitteesMeetingMaterials\/Drugs\/PharmacyCompoundingAdvisoryCommittee\/ucm486144.htm"},{"issue":"12","key":"10.1002\/14651858.CD011451.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nrn3587","article-title":"Hepatic encephalopathy: effects of liver failure on brain function","volume":"14","author":"Felipo","year":"2013","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0039|cit39","unstructured":"Fermi Paradox www.crystalinks.com\/fermiparadox.html"},{"issue":"1","key":"10.1002\/14651858.CD011451.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/MLR.0000000000000244","article-title":"The patient-centered outcomes research institute's role in advancing methods for patient-centered outcomes research","volume":"53","author":"Fleurence","year":"2015","journal-title":"Medical Care"},{"issue":"11","key":"10.1002\/14651858.CD011451.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/sim.4780141103","article-title":"Multivariate tests for multiple endpoints in clinical trials","volume":"14","author":"Follmann","year":"1995","journal-title":"Statistics in Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011451.pub2-BIB0042|cit42","first-page":"222","article-title":"Current concepts in the pathophysiology and management of hepatic encephalopathy","volume":"7","author":"Frederick","year":"2011","journal-title":"Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2288-8-32","article-title":"The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: a simulation study","volume":"8","author":"Friedrich","year":"2008","journal-title":"BMC Medical Research Methodology"},{"issue":"5","key":"10.1002\/14651858.CD011451.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jclinepi.2010.09.016","article-title":"Ratio of means for analyzing continuous outcomes in meta-analysis performed as well as mean difference methods","volume":"64","author":"Friedrich","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD011451.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11940-014-0297-2","article-title":"Management of hepatic encephalopathy","volume":"16","author":"Frontera","year":"2014","journal-title":"Current Treatment Options in Neurology"},{"issue":"6","key":"10.1002\/14651858.CD011451.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jclinepi.2004.09.013","article-title":"Uncertainty method improved on best-worst case analysis in a binary meta-analysis","volume":"58","author":"Gamble","year":"2005","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0047|cit47","unstructured":"Gartlehner G Nussbaumer-Streit B Wagner G Patel S Swinson-Evans T Dobrescu A Increased risks for random errors are common in outcomes graded as high certainty of evidence Journal of Clinical Epidemiology 10.1016\/j.jclinepi.2018.10.009"},{"issue":"5","key":"10.1002\/14651858.CD011451.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ijnurstu.2013.09.014","article-title":"Power, effects, confidence, and significance: an investigation of statistical practices in nursing research","volume":"51","author":"Gaskin","year":"2014","journal-title":"International Journal of Nursing Studies"},{"issue":"4","key":"10.1002\/14651858.CD011451.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jhep.2007.01.003","article-title":"Hepatology may have problems with putative surrogate outcome measures","volume":"46","author":"Gluud","year":"2007","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD011451.pub2-BIB0050|cit50","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003044.pub4","article-title":"Non-absorbable disaccharides versus placebo\/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis","author":"Gluud","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD011451.pub2-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001939.pub4","article-title":"Branched-chain amino acids for people with hepatic encephalopathy","author":"Gluud","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD011451.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.7326\/0003-4819-130-12-199906150-00019","article-title":"Toward evidence-based medical statistics. 2: the Bayes factor","volume":"130","author":"Goodman","year":"1999","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011451.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"282-90; discuss","DOI":"10.1191\/1740774505cn098oa","article-title":"Introduction to Bayesian methods I: measuring the strength of evidence","volume":"2","author":"Goodman","year":"2005","journal-title":"Clinical Trials"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0054|cit54","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro 2015"},{"issue":"4","key":"10.1002\/14651858.CD011451.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1: introduction - GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD011451.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2: framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD011451.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4: rating the quality of evidence - study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD011451.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5: rating the quality of evidence - publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD011451.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines: 6: rating the quality of evidence - imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD011451.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7: rating the quality of evidence - inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD011451.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8: rating the quality of evidence - indirectness","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD011451.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jclinepi.2011.06.004","article-title":"GRADE guidelines: 9: rating up the quality of evidence","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD011451.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11: making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD011451.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12: preparing Summary of Findings tables - binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD011451.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jclinepi.2012.08.001","article-title":"GRADE guidelines: 13: preparing Summary of Findings tables - continuous outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD011451.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","article-title":"GRADE guidelines: 15. going from evidence to recommendations: the significance and presentation of recommendations","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jclinepi.2017.05.005","article-title":"GRADE guidelines 17: assessing the risk of bias associated with missing participant outcome data in a body of evidence","volume":"87","author":"Guyatt","year":"2017","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0068|cit68","unstructured":"Hempel S Miles J Suttorp MJ Wang Z Johnsen B Morton S Detection of associations between trial quality and effect sizes www.ncbi.nlm.nih.gov\/books\/NBK84249\/pdf\/Bookshelf_NBK84249.pdf"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/2046-4053-2-107","article-title":"Risk of bias: a simulation study of power to detect study-level moderator effects in meta-analysis","volume":"2","author":"Hempel","year":"2013","journal-title":"Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD011451.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cld.2015.04.002","article-title":"Should we treat minimal\/covert hepatic encephalopathy, and with what?","volume":"19","author":"Henderson","year":"2015","journal-title":"Clinics in Liver Disease"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0071|cit71","doi-asserted-by":"crossref","unstructured":"Heneghan C Goldacre B Mahtani KR Why clinical trial outcomes fail to translate into benefits for patients Trials 2017 122","DOI":"10.1186\/s13063-017-1870-2"},{"issue":"7414","key":"10.1002\/14651858.CD011451.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0073|cit73","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"7211","key":"10.1002\/14651858.CD011451.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","article-title":"What is meant by intention to treat analysis? Survey of published randomised controlled trials","volume":"319","author":"Hollis","year":"1999","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"1","key":"10.1002\/14651858.CD011451.pub2-BIB0075|cit75","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003974.pub3","article-title":"Placebo interventions for all clinical conditions","author":"Hr\u00f3bjartsson","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0076|cit76","volume-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice CFR & ICH Guidelines","volume":"1","author":"International Conference on Harmonisation Expert Working Group","year":"1997"},{"issue":"6","key":"10.1002\/14651858.CD011451.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1213\/ANE.0000000000000892","article-title":"Systematic reviews of anesthesiologic interventions reported as statistically significant: problems with power, precision, and type 1 error protection","volume":"121","author":"Imberger","year":"2015","journal-title":"Anesthesia and Analgesia"},{"issue":"8","key":"10.1002\/14651858.CD011451.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"e011890","DOI":"10.1136\/bmjopen-2016-011890","article-title":"False-positive findings in Cochrane meta-analyses with and without application of trial sequential analysis: an empirical review","volume":"6","author":"Imberger","year":"2016","journal-title":"BMJ Open"},{"issue":"7","key":"10.1002\/14651858.CD011451.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"e010247","DOI":"10.1136\/bmjopen-2015-010247","article-title":"Plea for routinely presenting prediction intervals in meta-analysis","volume":"6","author":"IntHout","year":"2016","journal-title":"BMJ Open"},{"issue":"10","key":"10.1002\/14651858.CD011451.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-141-10-200411160-00009","article-title":"Better reporting of harms in randomized trials: an extension of the CONSORT statement","volume":"141","author":"Ioannidis","year":"2004","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0081|cit81","doi-asserted-by":"crossref","unstructured":"Ioannidis JP Adverse events in randomized trials: neglected, restricted, distorted, and silenced Archives of Internal Medicine 2009 1737 9","DOI":"10.1001\/archinternmed.2009.313"},{"issue":"3-4","key":"10.1002\/14651858.CD011451.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jrsm.19","article-title":"Meta-research: the art of getting it wrong","volume":"1","author":"Ioannidis","year":"2010","journal-title":"Research Synthesis Methods"},{"issue":"5","key":"10.1002\/14651858.CD011451.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1373\/clinchem.2016.254649","article-title":"Waste, leaks, and failures in the biomarker pipeline","volume":"63","author":"Ioannidis","year":"2017","journal-title":"Clinical Chemistry"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"j408","DOI":"10.1136\/bmj.j408","article-title":"Outcome reporting bias in clinical trials: why monitoring matters","volume":"356","author":"Ioannidis","year":"2017","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2288-14-120","article-title":"Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods","volume":"14","author":"Jakobsen","year":"2014","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2288-14-34","article-title":"The thresholds for statistical and clinical significance - a five-step procedure for evaluation of intervention effects in randomised clinical trials","volume":"14","author":"Jakobsen","year":"2014","journal-title":"BMC Medical Research Methodology"},{"issue":"2","key":"10.1002\/14651858.CD011451.pub2-BIB0087|cit87","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003047.pub3","article-title":"Dopamine agents for hepatic encephalopathy","author":"Junker","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD011451.pub2-BIB0088|cit88","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011585","article-title":"Rifaximin for people with hepatic encephalopathy","author":"Kimer","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"c365","DOI":"10.1136\/bmj.c365","article-title":"The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews","volume":"340","author":"Kirkham","year":"2010","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"11","key":"10.1002\/14651858.CD011451.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"19","key":"10.1002\/14651858.CD011451.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/0024-3205(96)00343-8","article-title":"Carnitine metabolism in chronic liver disease","volume":"59","author":"Kr\u00e4henb\u00fchl","year":"1996","journal-title":"Life Sciences"},{"issue":"1","key":"10.1002\/14651858.CD011451.pub2-BIB0092|cit92","first-page":"148","article-title":"Carnitine metabolism in patients with chronic liver disease","volume":"25","author":"Kr\u00e4henb\u00fchl","year":"1997","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"3","key":"10.1002\/14651858.CD011451.pub2-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/biomet\/70.3.659","article-title":"Discrete sequential boundaries for clinical trials","volume":"70","author":"Lan","year":"1983","journal-title":"Biometrika"},{"issue":"2","key":"10.1002\/14651858.CD011451.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.mayocp.2013.11.009","article-title":"Management of hepatic encephalopathy in the hospital","volume":"89","author":"Leise","year":"2014","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cct.2015.07.001","article-title":"Bayes factor and posterior probability: complementary statistical evidence to p-value","volume":"44","author":"Lin","year":"2015","journal-title":"Contemporary Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD011451.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.mcna.2013.09.006","article-title":"Management of end-stage liver disease","volume":"98","author":"Liou","year":"2014","journal-title":"Medical Clinics of North America"},{"issue":"2","key":"10.1002\/14651858.CD011451.pub2-BIB0097|cit97","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub3","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD011451.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/MOG.0b013e3283505a3b","article-title":"Carnitine derivatives: clinical usefulness","volume":"28","author":"Malaguarnera","year":"2012","journal-title":"Current Opinion in Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD011451.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11011-013-9376-4","article-title":"Acetyl-L-carnitine in hepatic encephalopathy","volume":"28","author":"Malaguarnera","year":"2013","journal-title":"Metabolic Brain Disease"},{"issue":"1","key":"10.1002\/14651858.CD011451.pub2-BIB0100|cit100","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006612.pub4","article-title":"Homocysteine-lowering interventions for preventing cardiovascular events","author":"Marti-Carvajal","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD011451.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1586\/egh.10.32","article-title":"Pathogenesis and diagnosis of hepatic encephalopathy","volume":"4","author":"McPhail","year":"2010","journal-title":"Expert Review of Gastroenterology & Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD011451.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0197-2456(94)00031-W","article-title":"Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists","volume":"16","author":"Moher","year":"1995","journal-title":"Controlled Clinical Trials"},{"issue":"9128","key":"10.1002\/14651858.CD011451.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD011451.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"795-812, viii","DOI":"10.1016\/j.mcna.2008.03.009","article-title":"Hepatic encephalopathy","volume":"92","author":"Munoz","year":"2008","journal-title":"Medical Clinics of North America"},{"issue":"7","key":"10.1002\/14651858.CD011451.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"736-42; quiz 74","DOI":"10.1016\/j.jclinepi.2013.02.004","article-title":"The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses","volume":"66","author":"Mustafa","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neures.2016.04.009","article-title":"Minimal hepatic encephalopathy: a review","volume":"111","author":"Nardone","year":"2016","journal-title":"Neuroscience Research"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jclinepi.2017.02.010","article-title":"Simple randomization did not protect against bias in smaller trials","volume":"84","author":"Nguyen","year":"2017","journal-title":"Journal of Clinical Epidemiology"},{"issue":"18","key":"10.1002\/14651858.CD011451.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.3748\/wjg.v20.i18.5442","article-title":"Cirrhosis and its complications: evidence based treatment","volume":"20","author":"Nusrat","year":"2014","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0109|cit109","doi-asserted-by":"crossref","unstructured":"Nuzzo R Scientific method: statistical errors Nature 2014 150 2","DOI":"10.1038\/506150a"},{"issue":"10","key":"10.1002\/14651858.CD011451.pub2-BIB0110|cit110","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000035.pub2","article-title":"Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions","author":"Page","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD011451.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/sim.7140","article-title":"Random effects meta-analysis: coverage performance of 95% confidence and prediction intervals following REML estimation","volume":"36","author":"Partlett","year":"2017","journal-title":"Statistics in Medicine"},{"issue":"12","key":"10.1002\/14651858.CD011451.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/j.cgh.2015.06.039","article-title":"Covert and overt hepatic encephalopathy: diagnosis and management","volume":"13","author":"Patidar","year":"2015","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD011451.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4254\/wjh.v4.i3.50","article-title":"Hepatic encephalopathy: an approach to its multiple pathophysiological features","volume":"4","author":"Perazzo","year":"2012","journal-title":"World Journal of Hepatology"},{"issue":"19","key":"10.1002\/14651858.CD011451.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1001\/archinternmed.2009.306","article-title":"Reporting of safety results in published reports of randomized controlled trials","volume":"169","author":"Pitrou","year":"2009","journal-title":"Archives of Internal Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011451.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1746-6342.2006.03215.x","article-title":"Review article: the burden of hepatic encephalopathy","volume":"25","author":"Poordad","year":"2007","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD011451.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/MOG.0b013e32835f43b0","article-title":"End-stage liver disease complications","volume":"29","author":"Rahimi","year":"2013","journal-title":"Current Opinion in Gastroenterology"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0117|cit117","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"d549","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0119|cit119","doi-asserted-by":"crossref","unstructured":"Romero-Gomez M Montagnese S Jalan R Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute on chronic liver failure Journal of Hepatology 2015 437 47","DOI":"10.1016\/j.jhep.2014.09.005"},{"issue":"4","key":"10.1002\/14651858.CD011451.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0266462303000552","article-title":"Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches","volume":"19","author":"Royle","year":"2003","journal-title":"International Journal of Technology Assessment in Health Care"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jclinepi.2017.02.005","article-title":"Clinical trials and systematic reviews addressing similar interventions for the same condition do not consider similar outcomes to be important: a case study in HIV\/AIDS","volume":"84","author":"Saldanha","year":"2017","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD011451.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"157","author":"Savovic","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"35","key":"10.1002\/14651858.CD011451.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16350","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies","volume":"16","author":"Savovic","year":"2012","journal-title":"Health Technology Assessment"},{"issue":"5","key":"10.1002\/14651858.CD011451.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/aje\/kwx344","article-title":"Association between risk-of-bias assessments and results of randomized trials in Cochrane Reviews: the ROBES Meta-Epidemiologic Study","volume":"187","author":"Savovi\u0107","year":"2018","journal-title":"American Journal of Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD011451.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"7","key":"10.1002\/14651858.CD011451.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1056\/NEJMp1313061","article-title":"PCORI at 3 years - progress, lessons, and plans","volume":"370","author":"Selby","year":"2014","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011451.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1442-200X.2001.01423.x","article-title":"Plasma and liver carnitine status of children with chronic liver disease and cirrhosis","volume":"43","author":"Selimoglu","year":"2001","journal-title":"Pediatrics International"},{"issue":"2","key":"10.1002\/14651858.CD011451.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/MEG.0000000000000529","article-title":"How to diagnose and manage hepatic encephalopathy: a consensus statement on roles and responsibilities beyond the liver specialist","volume":"28","author":"Shawcross","year":"2016","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"9","key":"10.1002\/14651858.CD011451.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1007\/s10620-007-0183-9","article-title":"Is oral L-acyl-carnitine an effective therapy for hepatic encephalopathy? Review of the literature","volume":"53","author":"Shores","year":"2008","journal-title":"Digestive Diseases and Sciences"},{"issue":"9","key":"10.1002\/14651858.CD011451.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.cgh.2012.05.016","article-title":"In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009","volume":"10","author":"Stepanova","year":"2012","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"5","key":"10.1002\/14651858.CD011451.pub2-BIB0132|cit132","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012069.pub2","article-title":"Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies","author":"Storeb\u00f8","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD011451.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1586\/17474124.2014.858598","article-title":"Recent insights into the pathogenesis of hepatic encephalopathy and treatments","volume":"8","author":"Sturgeon","year":"2014","journal-title":"Expert Review of Gastroenterology & Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD011451.pub2-BIB0134|cit134","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008177","article-title":"Naloxone for hepatic encephalopathy","author":"Sun","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD011451.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.2013.285063","article-title":"How to use a subgroup analysis: users' guide to the medical literature","volume":"311","author":"Sun","year":"2014","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD011451.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"819-36, vii","DOI":"10.1016\/j.mcna.2009.03.009","article-title":"Hepatic encephalopathy: pathophysiology and emerging therapies","volume":"93","author":"Sundaram","year":"2009","journal-title":"Medical Clinics of North America"},{"issue":"3","key":"10.1002\/14651858.CD011451.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"e2000797","DOI":"10.1371\/journal.pbio.2000797","article-title":"Empirical assessment of published effect sizes and power in the recent cognitive neuroscience and psychology literature","volume":"15","author":"Szucs","year":"2017","journal-title":"PLoS Biology"},{"issue":"1","key":"10.1002\/14651858.CD011451.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ije\/dyn179","article-title":"Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses","volume":"38","author":"Thorlund","year":"2009","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0139|cit139","first-page":"57","article-title":"Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals","volume":"2","author":"Thorlund","year":"2010","journal-title":"Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0140|cit140","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User manual for Trial Sequential Analysis (TSA) ctu.dk\/tsa\/files\/tsa_manual.pdf"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0141|cit141","unstructured":"Copenhagen Trial Unit TSA - Trial Sequential Analysis 2011"},{"issue":"11","key":"10.1002\/14651858.CD011451.pub2-BIB0142|cit142","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000030.pub2","article-title":"Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals","author":"Turner","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD011451.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jclinepi.2013.05.016","article-title":"Single-center trials tend to provide larger treatment effects than multicenter trials: a systematic review","volume":"66","author":"Unverzagt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD011451.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12874-015-0024-z","article-title":"The heterogeneity statistic I(2) can be biased in small meta-analyses","volume":"15","author":"Hippel","year":"2015","journal-title":"BMC Medical Research Methodology"},{"issue":"9","key":"10.1002\/14651858.CD011451.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3949\/ccjm.78a10117","article-title":"Hepatic encephalopathy: suspect it early in patients with cirrhosis","volume":"78","author":"Wakim-Fleming","year":"2011","journal-title":"Cleveland Clinic Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD011451.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/jnnp.52.8.940","article-title":"Fatigue syndromes: a comparison of chronic \"postviral\" fatigue with neuromuscular and affective disorders","volume":"52","author":"Wessely","year":"1989","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD011451.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in random-effects model meta-analyses","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"issue":"1","key":"10.1002\/14651858.CD011451.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial sequential analysis in systematic reviews with meta-analysis","volume":"17","author":"Wetterslev","year":"2017","journal-title":"BMC Medical Research Methodology"},{"issue":"12","key":"10.1002\/14651858.CD011451.pub2-BIB0151|cit151","first-page":"1454","article-title":"Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation","volume":"20","author":"Wong","year":"2014","journal-title":"Liver Transplantation"},{"issue":"7644","key":"10.1002\/14651858.CD011451.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD011451.pub2-BIB0153|cit153","unstructured":"Zavala D Mart\u00ed A Pe\u00f1a-Mart\u00ed G Comuni\u00e1n G Sheet to enter data for performing a Cochrane review 2006"},{"issue":"12","key":"10.1002\/14651858.CD011451.pub2-BIB0154|cit154","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011451","article-title":"Acetyl-L-carnitine for patients with hepatic encephalopathy","author":"Mart\u00ed-Carvajal","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD011451.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T01:33:37Z","timestamp":1681090417000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011451.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,5]]},"references-count":154,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011451.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,5]]}}}